相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The potential of heparanase as a therapeutic target in cancer
Claudio Pisano et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Heparanase expression and localization in different types of human lung cancer
Teresa Cristina Fernandes dos Santos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies
Michel Record et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival
Yunping Hu et al.
CARCINOGENESIS (2014)
Heparanase as a Target in Cancer Therapy
Valentina Masola et al.
CURRENT CANCER DRUG TARGETS (2014)
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer
Tibor Szarvas et al.
HUMAN PATHOLOGY (2014)
Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer
Xiaoping He et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Heparan Sulfate Containing Unsubstituted Glucosamine Residues BIOSYNTHESIS AND HEPARANASE-INHIBITORY ACTIVITY
Satomi Nadanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Ovarian Cancer Cell Heparan Sulfate 6-O-Sulfotransferases Regulate an Angiogenic Program Induced by Heparin-binding Epidermal Growth Factor ( EGF)-like Growth Factor/EGF Receptor Signaling
Claire L. Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
TGF-β1 and FGF2 Stimulate the Epithelial-Mesenchymal Transition of HERS Cells Through a MEK-Dependent Mechanism
Jie Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Expression of heparanase in soft tissue sarcomas of adults
Olga Kazarin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Synthesis and Biological Evaluation of a Unique Heparin Mimetic Hexasaccharide for Structure-Activity Relationship Studies
Sucharita Roy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Heparanase enhances myeloma progression via CXCL10 downregulation
U. Barash et al.
LEUKEMIA (2014)
Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors
K. E. Hunter et al.
ONCOGENE (2014)
Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance
Fei Xia et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Syndecans as modulators and potential pharmacological targets in cancer progression
Despoina Barbouri et al.
FRONTIERS IN ONCOLOGY (2014)
Post-synthetic regulation of HS structure: the yin and yang of the Sulfs in cancer
Romain R. Vives et al.
FRONTIERS IN ONCOLOGY (2014)
Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D
Kar Wai Tan et al.
BLOOD (2013)
Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer
Ivan Fernandez-Vega et al.
BMC CANCER (2013)
Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease
Jian Ruan et al.
BONE (2013)
MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
Longlong Bao et al.
CANCER LETTERS (2013)
Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes
Takuya Shirakihara et al.
CANCER SCIENCE (2013)
Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts
Ashwani Khurana et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer
Dabei Tang et al.
CLINICAL BIOCHEMISTRY (2013)
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies
Vishnu C. Ramani et al.
FEBS JOURNAL (2013)
The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling
Xin Zheng et al.
GENES CHROMOSOMES & CANCER (2013)
Human sulfatase-1 inhibits the migration and proliferation of SMMC-7721 hepatocellular carcinoma cells by downregulating the growth factor signaling
Hu Liu et al.
HEPATOLOGY RESEARCH (2013)
被撤回的出版物: Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase (Retracted article. See vol. 48, pg. 188, 2021)
Yang Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Activation of the Transcription Factor GLI1 by WNT Signaling Underlies the Role of SULFATASE 2 as a Regulator of Tissue Regeneration
Ikuo Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes
Camilla A. Thompson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Heparanase expression correlates with poor survival in oral mucosal melanoma
Xin Wang et al.
MEDICAL ONCOLOGY (2013)
Heparanase overexpression participates in tumor growth of cervical cancer in vitro and in vivo
Chao Zeng et al.
MEDICAL ONCOLOGY (2013)
EGFR, FLT1 and Heparanase as Markers Identifying Patients at Risk of Short Survival in Cholangiocarcinoma
Andreas-Claudius Hoffmann et al.
PLOS ONE (2013)
Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression
Angelica M. Gomes et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues
Edward Hammond et al.
FEBS OPEN BIO (2013)
The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors
Tunde Szatmari et al.
FRONTIERS IN ONCOLOGY (2013)
Endo-sulfatase Sulf-1 Protein Expression is Down-regulated in Gastric Cancer
Gopisetty Gopal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Molecular Model of Human Heparanase with Proposed Binding Mode of a Heparan Sulfate Oligosaccharide and Catalytic Amino Acids
Nicolas Sapay et al.
BIOPOLYMERS (2012)
Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-d-glucuronidase (heparanase)
Neha S. Gandhi et al.
GLYCOBIOLOGY (2012)
The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer
Ping Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells
Valentina Masola et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Deciphering Mode of Action of Heparanase Using Structurally Defined Oligosaccharides
Sherket Peterson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma
Joanna J. Phillips et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer
Keun Hur et al.
JOURNAL OF PATHOLOGY (2012)
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
Valentina Masola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Heparanase-Induced GEF-H1 Signaling Regulates the Cytoskeletal Dynamics of Brain Metastatic Breast Cancer Cells
Lon D. Ridgway et al.
MOLECULAR CANCER RESEARCH (2012)
Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell lines
Ashwani Khurana et al.
MOLECULAR CARCINOGENESIS (2012)
PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model
Edward Hammond et al.
PLOS ONE (2012)
The expression of heparanase and microRNA-1258 in human non-small cell lung cancer
Hongcheng Liu et al.
TUMOR BIOLOGY (2012)
SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study
Natalie Shaubie Lui et al.
BMJ OPEN (2012)
Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers?
Ruowen Ge et al.
CANCER MICROENVIRONMENT (2012)
Significance of Heparanase in Cancer and Inflammation
Israel Vlodavsky et al.
CANCER MICROENVIRONMENT (2012)
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo
Ashwani Khurana et al.
BREAST CANCER RESEARCH (2012)
NF-κB Is the Transcription Factor for FGF-2 That Causes Endothelial Mesenchymal Transformation in Cornea
Jeong Goo Lee et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
K. Dredge et al.
BRITISH JOURNAL OF CANCER (2011)
Abstract 5459: Antitumor activity of EP80061, a small-glyco drug in preclinical studies
Vanessa Nancy-Portebois et al.
CANCER RESEARCH (2011)
HSulf-1 Modulates FGF2-and Hypoxia-Mediated Migration and Invasion of Breast Cancer Cells
Ashwani Khurana et al.
CANCER RESEARCH (2011)
Targeting tumour heparanase activity using fully human monoclonal antibodies
Palaniswami Rathanaswami et al.
CANCER RESEARCH (2011)
HSulf-1 inhibits cell proliferation and invasion in human gastric cancer
Jie Li et al.
CANCER SCIENCE (2011)
SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis
Joseph P. Ritchie et al.
CLINICAL CANCER RESEARCH (2011)
Sulfatase 1 and Sulfatase 2 in Hepatocellular Carcinoma: Associated Signaling Pathways, Tumor Phenotypes, and Survival
Ju Dong Yang et al.
GENES CHROMOSOMES & CANCER (2011)
Heparanase expression in head and neck squamous cell carcinomas is associated with reduced proliferation and improved survival
Carolin Mogler et al.
HISTOPATHOLOGY (2011)
Pre-clinical and clinical significance of heparanase in Ewing's sarcoma
Itay Shafat et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor
Soo-Hyun Kim et al.
JOURNAL OF ENDOCRINOLOGY (2011)
SULFs in human neoplasia: implication as progression and prognosis factors
Caroline Bret et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis
He Zhou et al.
PLOS ONE (2011)
HSulf-1 suppresses cell growth and down-regulates Hedgehog signaling in human gastric cancer cells
Hui-Yan Ma et al.
ONCOLOGY LETTERS (2011)
Impact of Heparanase and the Tumor Microenvironment on Cancer Metastasis and Angiogenesis: Basic Aspects and Clinical Applications
Israel Vlodavsky et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2011)
Relationship Between Serum Heparanase and Microscopic Venous Invasion in Patients With Hepatocellular Carcinoma
Gui-Bo Wang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features
Chao Cheng et al.
APMIS (2010)
Proteolytic cleavage of the rat heparan sulfate 6-O-endosulfatase SulfFP2 by furin-type proprotein convertases
Satoshi Nagamine et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
Anurag Purushothaman et al.
BLOOD (2010)
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate
Steven D. Rosen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88
Md Motarab Hossain et al.
GLYCOBIOLOGY (2010)
The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3-Dependent Wnt Activation
Jin-Ping Lai et al.
HEPATOLOGY (2010)
Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma
Ryotaro Sonoda et al.
HISTOPATHOLOGY (2010)
The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
K. Dredge et al.
INVESTIGATIONAL NEW DRUGS (2010)
Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors
Jin-Ping Lai et al.
LIVER INTERNATIONAL (2010)
Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis
H. Lemjabbar-Alaoui et al.
ONCOGENE (2010)
Hypoxia activates heparanase expression in an NF-kappa B dependent manner
Wujun Wu et al.
ONCOLOGY REPORTS (2010)
Abnormal expression of early growth response 1 in gastric cancer: Association with tumor invasion, metastasis and heparanase transcription
Liduan Zheng et al.
PATHOLOGY INTERNATIONAL (2010)
Marine-derived oligosaccharide sulfate (JG3) suppresses heparanase-driven cell adhesion events in heparanase over-expressing CHO-K1 cells
Qiu-ning Li et al.
ACTA PHARMACOLOGICA SINICA (2009)
Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer
Peng Liu et al.
CANCER RESEARCH (2009)
A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity
Amrit Paul Sahota et al.
EXPERIMENTAL CELL RESEARCH (2009)
Functional Consequences of the Subdomain Organization of the Sulfs
Renhong Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
PI-88: a novel inhibitor of angiogenesis
Ragini Kudchadkar et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
Jin-Ping Lai et al.
HEPATOLOGY (2008)
Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment
Ghada Abboud-Jarrous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
Anurag Purushothaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of heparanase in hepatocellular carcinoma has prognostic significance: A tissue microarray study
Gang Chen et al.
ONCOLOGY RESEARCH (2008)
Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate
Martha L. Escobar Galvis et al.
NATURE CHEMICAL BIOLOGY (2007)
Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies
O. Ostrovsky et al.
LEUKEMIA (2007)
Heparanase induces Akt phosphorylation via a lipid raft receptor
Olga Ben-Zaken et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation
Xingbin Ai et al.
DEVELOPMENT (2007)
Epigenetic silencing of HSulf-1 in ovarian cancer: implications in chemoresistance
J. Staub et al.
ONCOGENE (2007)
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
Karene Mahtouk et al.
BLOOD (2007)
Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation
Gui Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer
Keishi Narita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Heparanase enhances syndecan-1 shedding - A novel mechanism for stimulation of tumor growth and metastasis
Yang Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mammalian heparanase: what is the message?
Veronique Vreys et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Heparanase: a target for drug discovery in cancer and inflammation
E. A. McKenzie
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Extracellular Sulfatases, Elements of the Wnt Signaling Pathway, Positively Regulate Growth and Tumorigenicity of Human Pancreatic Cancer Cells
Roman Nawroth et al.
PLOS ONE (2007)
Heparanase promotes angiogenesis through Cox-2 and HIF1 alpha
Yoshio Naomoto et al.
MEDICAL HYPOTHESES (2007)
Heparanase localization and expression by head and neck cancer: Correlation with tumor progression and patient survival
Ilana Doweck et al.
NEOPLASIA (2006)
Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design
Zhigang Zhou et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin
Peisong Ma et al.
JOURNAL OF CELL BIOLOGY (2006)
Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis
Huajun Zhao et al.
CANCER RESEARCH (2006)
FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells
Jane Reiland et al.
NEOPLASIA (2006)
HSulf-1 inhibits angiogenesis and tumorigenesis in vivo
Keishi Narita et al.
CANCER RESEARCH (2006)
SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma
Jin-Ping Lai et al.
GASTROENTEROLOGY (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival
RM Quiros et al.
CANCER (2006)
N-(4-{[4-(1H-benzoimidazol-2-yl)-arylaminol-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors
YJ Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
1-[4-(1H-benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors
WT Pan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Development of heparanase inhibitors for anti-cancer therapy
Hua-Quan Miao et al.
CURRENT MEDICINAL CHEMISTRY (2006)
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo
YM Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer
JA Joyce et al.
ONCOGENE (2005)
Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase
F Levy-Adam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor
SM Courtney et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples
ZN Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis
P Beckhove et al.
CLINICAL CANCER RESEARCH (2005)
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
Junsheng Li et al.
MOLECULAR CANCER (2005)
Novel heparan sulfate mimetic compounds as antitumor agents
K Ishida et al.
CHEMISTRY & BIOLOGY (2004)
HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma
JP Lai et al.
ONCOGENE (2004)
Exploitation of heparanase inhibitors from microbial metabolites using an efficient visual screening system
K Ishida et al.
JOURNAL OF ANTIBIOTICS (2004)
2,3-dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives:: a novel class of small molecule heparanase inhibitors
SM Courtney et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling
JP Lai et al.
GASTROENTEROLOGY (2004)
Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies
XT He et al.
CANCER RESEARCH (2004)
Heparanase induces endothelial cell migration via protein kinase B/Akt activation
S Gingis-Velitski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer
JP Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Heparanase expression correlates with invasion and poor prognosis in gastric cancers
M Takaoka et al.
LABORATORY INVESTIGATION (2003)
Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans
M Morimoto-Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis - Hierarchical sulfate groups with differential effects and the essential target disulfated trisaccharide sequence
Y Okada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Heparanase: A key enzyme in invasion and metastasis of gastric carcinoma
WH Tang et al.
MODERN PATHOLOGY (2002)
Heparanase and platelet factor-4 induce smooth muscle cell proliferation and migration via bFGF release from the ECM
HA Myler et al.
JOURNAL OF BIOCHEMISTRY (2002)
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
J Rohloff et al.
BRITISH JOURNAL OF CANCER (2002)
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
PWB Derksen et al.
BLOOD (2002)
Determination of the composition of the oligosaccharide phosphate fraction of Pichia (Hansenula) holstii NRRL Y-2448 phosphomannan by capillary electrophoresis and HPLC
V Ferro et al.
CARBOHYDRATE RESEARCH (2002)
Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias
PO Iversen et al.
LEUKEMIA (2002)
Heparanase expression in human leukemias is restricted to acute myeloid leukemias
M Bitan et al.
EXPERIMENTAL HEMATOLOGY (2002)
Heparanase as mediator of angiogenesis: mode of action
M Elkin et al.
FASEB JOURNAL (2001)
Identification of active-site residues of the pro-metastatic endoglycosidase heparanase
MD Hulett et al.
BIOCHEMISTRY (2000)
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
CM Alexander et al.
NATURE GENETICS (2000)
分享论文
